External Validation os the ACME Scoring System
Launched by HOSPITAL DEL MAR · Jan 18, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new scoring system called ACME, which aims to predict the risk of death in patients with a condition called acute cholecystitis, a common emergency that often requires surgery. The goal of the study is to test whether this scoring system works well in real-world situations and can help doctors make better decisions about who is fit for surgery, especially since some patients may be more fragile and at higher risk.
To be eligible for the trial, participants should be adults aged 65 and older who have been diagnosed with acute calculous cholecystitis. However, those with other serious conditions like acute cholangitis, chronic cholecystitis, certain cancers, or acute pancreatitis, as well as pregnant individuals, cannot participate. If you join the study, you can expect to have your health evaluated based on the ACME scoring system to see how well it predicts outcomes for patients with this condition. It's important to note that the trial is not yet recruiting participants, so there will be more details to come as it gets underway.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Acute Calculous Cholecystitis
- Exclusion Criteria:
- • Acute Cholangitis
- • Chronic Cholecystitis
- • Neoplasia
- • Acute Pancreatitis
- • Pregnant
About Hospital Del Mar
Hospital del Mar is a leading healthcare institution located in Barcelona, Spain, renowned for its commitment to medical excellence and patient care. As a prominent clinical trial sponsor, Hospital del Mar actively engages in innovative research aimed at advancing medical knowledge and improving therapeutic outcomes across various specialties. The hospital boasts a multidisciplinary team of experienced researchers and healthcare professionals dedicated to conducting rigorous clinical trials in accordance with the highest ethical and regulatory standards. Through collaboration with academic institutions and industry partners, Hospital del Mar strives to translate research findings into tangible benefits for patients, enhancing the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Ana María González Castillo, PhD
Principal Investigator
Hospital del Mar
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported